Trial Profile
Phase I/II study of CTAP101 Capsules for the treatment of vitamin D insufficiency in chronic kidney disease (CKD)
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 20 Jan 2017
Price :
$35
*
At a glance
- Drugs Calcifediol (Primary)
- Indications Vitamin D deficiency
- Focus Pharmacokinetics
- 20 Jan 2017 According to OPKO Health website, this trial was originally conducted by Cytochroma which later on was acquired by OPKO Health and now the name changed to OPKO Renal in March 2013.
- 27 May 2016 New trial record